Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1967;36:294-303

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HURST, V. W.
Right arrow Articles by MCINTOSH, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HURST, V. W., III
Right arrow Articles by MCINTOSH, H. D.

(Circulation. 1967;36:294.)
© 1967 American Heart Association, Inc.


Increased Survival with Prophylactic Quinidine After Experimental Myocardial Infarction

VICTOR W. HURST III M.D.1; JAMES J. MORRIS JR. M.D.1; HOWARD J. ZEFT M.D.1; DONALD B. HACKEL M.D.1; HENRY D. MCINTOSH M.D.1

1 From the Cardiovascular Laboratory, Department of Medicine, and the Department of Pathology, Duke University Medical Center, Durham, North Carolina.

Experimental myocardial infarction was produced in 60 farm pigs by gradual coronary occlusion with an Ameroid constrictor placed around the left anterior descending coronary artery. Twenty animals were treated with 10 mg/kg/6 hr of quinidine, 10 with 5 mg/kg/6 hr, and 10 with 2.5 mg/kg/6 hr for a total period of 72 hours. Twenty animals served as controls. Serum quinidine levels were measured at 6-hour intervals. Significantly increased survival, when compared to controls, were observed in those animals treated with 5 and 10 mg/kg/6 hr of quinidine, but not in those receiving 2.5 mg/kg/6 hr. Under the described experimental conditions, designed to cause a reproducible, consistent infarction, quinidine treatment in nontoxic and well-tolerated doses significantly increased survival. Furthermore, there is a dose level below which this effect is lost. Whether the results of this study are applicable to man in preventing sudden death is unknown.


Key Words: Ameroid constrictor • Gradual coronary occlusion




This article has been cited by other articles:


Home page
Arch Intern MedHome page
J. Koch-Weser
Antiarrhythmic Prophylaxis in Ambulatory Patients With Coronary Heart Disease
Arch Intern Med, May 1, 1972; 129(5): 763 - 772.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
D. P. Zipes
Treatment of Arrhythmias in Myocardial Infarction
Arch Intern Med, July 1, 1969; 124(1): 101 - 109.
[Abstract] [PDF]